Blue Crest Capital Management LTD Sarepta Therapeutics, Inc. Transaction History

Blue Crest Capital Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $215,967 - $382,606	-2,822 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $205,469 - $442,800	2,822 New	2,822 $213,000
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $1.87 Million - $2.53 Million	-16,647 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $1.78 Million - $2.53 Million	16,647 New	16,647 $1.98 Million
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $1.64 Million - $2.5 Million	-16,819 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $4.82 Million - $6.75 Million	-41,810 Reduced 71.31%	16,819 $2.72 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $3.89 Million - $8.33 Million	54,220 Added 1229.76%	58,629 $7.75 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $238,174 - $362,728	4,409 New	4,409 $327,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.